EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucokinase Regulatory Protein as a Putative Target for Gestational Diabetes Mellitus and Related Complications: Evidence From the Mendelian Randomization Study

Weian Mao, Guiquan Wang, Xiao Wang, Yan Shen, Shuai Yuan, Lin Wang, Haiyan Yang, Yan Li, Kai Chen, Jun Liu, Xi Dong, Yue Zhao und 1 weitere

Journal of Diabetes · 2025

DOI: 10.1111/1753-0407.70056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, 2025. Verfasst von Weian Mao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy and is highly associated with adverse perinatal outcomes and long‐term health problems for the mother and offspring. However, there are respective limitations in the pharmacological strategies for the current treatment of GDM. Glucokinase regulatory protein (GCKR) has been associated with GDM in observational studies and animal experiments and thus represents a potential drug target of interest for investigation.

Methods

We applied two‐sample Mendelian randomization (MR) and colocalization analysis using summary‐level data from genome‐wide association studies of GCKR and GDM. Two‐step MR was used to explore the mediating effects of several metabolic factors on the association. We also applied MR to explore the associations of GCKR levels with GDM‐related outcomes. Finally, we performed a phenome‐wide association study (PheWAS) to query the potential effects of altered GCKR levels across multiple health categories.

Results

We found a significant association between elevated GCKR levels and GDM (OR = 3.466, 95% CI = 2.401–5.002, p = 3.16 × 10 −11 ), also supported by the colocalization analysis ([ P coloc ] = 0.997). The estimates were replicated in an independent study (OR = 2.640, 95% CI = 1.983–3.513, p = 2.84 × 10 −11 , P coloc = 0.983). Elevated GCKR levels were also associated with higher risk of type 2 diabetes (OR = 2.183, 95% CI = 1.846–2.581, p = 6.53 × 10 −20 ). Two‐step MR suggested that fasting glucose, fasting insulin, and triglycerides partly mediated the causal relationship. PheWAS found that targeting GCKR may improve renal function and glucose homeostasis but cause dyslipidemia and uric acid abnormalities.

Conclusions

This study provided novel evidence that circulating GCKR levels are causally implicated in GDM and related complications, suggesting that it may be a promising target for treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalAdaptor Proteins, Signal TransducingHumansPregnancyMendelian Randomization AnalysisFemaleGenome-Wide Association StudyPolymorphism, Single NucleotideCarrier Proteins

Stichwörter der Autor:innen

Mendelian randomizationgestational diabetes mellitusglucokinase regulatory protein

Substanzen

Adaptor Proteins, Signal TransducingGCKR protein, humanglucokinase regulatory proteinCarrier Proteins

Autor:innen und Institutionen

  • Reproductive Medicine Center, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Reproductive Medicine, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, China; Xiamen Key Laboratory of Reproduction and Genetics, Xiamen, China.
  • Department of Obstetrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • The First School of Medicine, Wenzhou Medical University, Wenzhou, China.
  • Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Liangshan Mu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Mao, W., Wang, G., Wang, X., Shen, Y., Yuan, S., Wang, L., Yang, H., Li, Y., Chen, K., Liu, J., Dong, X., Zhao, Y., & Mu, L. (2025). Glucokinase Regulatory Protein as a Putative Target for Gestational Diabetes Mellitus and Related Complications: Evidence From the Mendelian Randomization Study. Journal of Diabetes. https://doi.org/10.1111/1753-0407.70056

Vancouver

Mao W, Wang G, Wang X, Shen Y, Yuan S, Wang L, et al. Glucokinase Regulatory Protein as a Putative Target for Gestational Diabetes Mellitus and Related Complications: Evidence From the Mendelian Randomization Study. Journal of Diabetes. 2025. doi:10.1111/1753-0407.70056

BibTeX
@article{Mao2025,
  author = {Mao, Weian and Wang, Guiquan and Wang, Xiao and Shen, Yan and Yuan, Shuai and Wang, Lin and Yang, Haiyan and Li, Yan and Chen, Kai and Liu, Jun and Dong, Xi and Zhao, Yue and Mu, Liangshan},
  title = {Glucokinase Regulatory Protein as a Putative Target for Gestational Diabetes Mellitus and Related Complications: Evidence From the Mendelian Randomization Study},
  journal = {Journal of Diabetes},
  year = {2025},
  doi = {10.1111/1753-0407.70056}
}
Kostenlos starten →